Tower Research Capital (TRC)’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Tower Research Capital (TRC)’s Portfolio IBDS Stock Details IBDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.23K	Sell	92 -968	-91%	-$23.5K	﹤0.01%	4514
2025 Q4	$25.7K	Sell	1,060 -1,131	-52%	-$27.5K	﹤0.01%	2911
2025 Q3	$53.3K	Sell	2,191 -5,685	-72%	-$138K	﹤0.01%	2482
2025 Q2	$191K	Buy	7,876 +6,633	+534%	+$160K	0.01%	1821
2025 Q1	$30.1K	Buy	+1,243	New	+$29.9K	﹤0.01%	2611
2024 Q3	–	Sell	-100	Closed	-$2.37K	–	5834
2024 Q2	$2.37K	Hold	100	–	–	﹤0.01%	5009
2024 Q1	$2.38K	Hold	100	–	–	﹤0.01%	5052
2023 Q4	$2.39K	Hold	100	–	–	﹤0.01%	5224
2023 Q3	$2.31K	Hold	100	–	–	﹤0.01%	5171
2023 Q2	$2.35K	Buy	+100	New	+$2.37K	﹤0.01%	5212

Other funds holding IBDS

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

SVWAG

Sound View Wealth Advisors Group Savannah, Georgia $1.47B AUM 18.47% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.22B AUM 22.28% 1-Year Est. Return

Tower Research Capital (TRC)'s IBDS Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 91% in Q1 2026, selling an estimated $23.5K and leaving 92 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #4514.

Tower Research Capital (TRC) first reported a position in IBDS in Q2 2023 and has held it in 10 quarters since. The position peaked at $191K in Q2 2025. 428 funds tracked by Wall St. Rank hold IBDS as of Q1 2026.

Tower Research Capital (TRC) held 92 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $2.23K as of Q1 2026.
Tower Research Capital (TRC) sold 968 iShares iBonds Dec 2027 Term Corporate ETF shares in Q1 2026, an estimated $23.5K.
iShares iBonds Dec 2027 Term Corporate ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4514 holding.
Tower Research Capital (TRC) first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2023 and has held it in 10 quarters since.
Tower Research Capital (TRC)'s iShares iBonds Dec 2027 Term Corporate ETF position peaked at $191K in Q2 2025.
428 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.